Histogenics Corp.
(NASDAQ : HSGX)

( )
HSGX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.69%183.171.3%$509.31m
CELGCelgene Corporation
-0.84%92.411.3%$442.42m
ARRYArray BioPharma Inc.
-0.20%46.128.1%$426.45m
GILDGilead Sciences, Inc.
-2.63%66.680.9%$400.32m
BIIBBiogen Inc.
-0.92%238.071.3%$377.86m
ILMNIllumina, Inc.
-0.48%356.373.5%$303.03m
REGNRegeneron Pharmaceuticals, Inc.
-2.50%305.082.6%$243.93m
VRTXVertex Pharmaceuticals Incorporated
-1.38%177.661.9%$210.42m
ALXNAlexion Pharmaceuticals, Inc.
0.15%125.342.0%$206.43m
EXASExact Sciences Corporation
1.20%112.7924.1%$187.08m
AAgilent Technologies, Inc.
-0.46%72.181.6%$154.39m
BMRNBioMarin Pharmaceutical Inc.
-1.04%82.954.3%$124.74m
SRPTSarepta Therapeutics, Inc.
3.37%128.3414.7%$119.55m
INCYIncyte Corporation
-2.26%85.632.5%$112.69m
MRTXMirati Therapeutics Inc.
-2.09%100.012.5%$104.17m

Company Profile

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.